ROYAL BANK OF CANADA - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$29,000
+123.1%
9,999
+122.9%
0.00%
Q2 2023$13,000
+8.3%
4,485
+10.5%
0.00%
Q1 2023$12,000
-33.3%
4,057
-54.0%
0.00%
Q4 2022$18,000
+1700.0%
8,816
+3818.2%
0.00%
Q3 2022$1,000225
+127.3%
0.00%
Q2 2022$0
-100.0%
99
-96.0%
0.00%
Q1 2022$17,0002,447
+4431.5%
0.00%
Q4 2021$0540.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Imprint Wealth LLC 257,119$938,4120.62%
Endowment Wealth Management, Inc. 96,618$298,5500.30%
Prescott General Partners LLC 568,246$1,755,8800.14%
HAMILTON LANE ADVISORS LLC 52,693$1630.06%
United Asset Strategies, Inc. 58,960$182,1860.02%
Kovack Advisors, Inc. 35,000$108,1500.02%
Shay Capital LLC 19,987$61,7600.01%
Y-Intercept (Hong Kong) Ltd 14,565$45,0060.01%
Mendota Financial Group, LLC 500$3,5300.00%
PHILADELPHIA TRUST CO 10,000$310.00%
View complete list of HUMACYTE INC shareholders